Kezdőlap・Részvénylista・Accuray Inc

Accuray Inc

Lezárt

SzektorEgészségügy

0.27 -12.9

Vétel Eladás

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

0.28

Maximum

0.31

Fő mutatók
By Trading Economics
Bevétel	2M -12M
Értékesítés	2.6M 105M
Egy részvényre jutó nyereség	-0.07
Profit margin	-11.259
Munkavállalók	990
EBITDA	2.5M -813K

Ajánlások
By TipRanks
Ajánlások	Semleges
12 hónapos előrejelzés	+12.9% upside

Osztalékok
By Acuity
Következő eredményjelentés	2026. aug. 12.

Piaci statisztika
By TradingEconomics
Piaci kapitalizáció	-22M 32M
Előző nyitás	13.17
Előző zárás	0.27

Hangulat hírek alapján

By Acuity

50%

175 / 340 Rangsor szerint Healthcare

Accuray Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. aug. 4. 20:02 UTC

Accuray Inc shares are higher today amid positive market sentiment and declining crude oil prices. Comments on potential peace talks with Iran also support the move.

2026. aug. 3. 19:31 UTC

Accuray Inc shares are lower today, with no specific news identified to explain the decline, despite broader market gains.

2026. júl. 31. 23:16 UTC

Accuray Inc shares are lower in after-market trading, with no specific news identified. Broader market pressures also impacted other tech companies, including Apple Inc.

2026. júl. 30. 23:51 UTC

Accuray Inc shares are lower in after-market hours, with no specific news identified for the decline. Broader market conditions remain mixed amid geopolitical concerns.

2026. júl. 29. 23:02 UTC

News

Accuray Inc. announced a $40 million debt exchange and $15 million equity investment to enhance its financial position, with shares trading higher after market close.

2026. júl. 28. 23:16 UTC

Accuray Inc shares are trading lower in after-market hours, reflecting broader market pressures in the technology sector amid concerns over AI spending and competition.

2026. júl. 27. 19:32 UTC

Accuray Inc's shares are declining today, hitting a low after an early high. Broader market conditions, including falling oil prices, may be influencing sentiment.

2026. júl. 24. 19:11 UTC

Accuray Inc's shares are higher today, driven by gains in the Health Care Equipment sub-sector. The stock remains near its one-month low.

2026. júl. 22. 18:51 UTC

Accuray Inc. shares are trading flat, remaining 7.82% below their 20-day moving average amid a lack of upward momentum.

2026. júl. 20. 19:31 UTC

Accuray Inc shares are lower today, diverging from a recent trend of higher closes. Broader market dynamics may be impacting investor sentiment.

Társak összehasonlítása

Árváltozás

Accuray Inc Előrejelzés

Célár

By TipRanks

12.9% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 0.35 USD 12.9%

Magas 0.35 USD

Alacsony 0.35 USD

1 Wall Street elemző 12 hónapos célárain alapulva a(z)Accuray Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Semleges

1 ratings

Vétel

Tartás

Eladás

1 Wall Street elemző célárain alapulva a(z)Accuray Inc termékhez az elmúlt 3 hónapban.

Hangulat

By Acuity

175 / 340 Rangsor szerint Egészségügy

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

Rólunk Accuray Inc

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.